Citadel Advisors’s Quipt Home Medical QIPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-46,000
| Closed | -$120K | – | 13805 |
|
|
2025
Q3 | $120K | Buy |
+46,000
| New | +$106K | ﹤0.01% | 11704 |
|
|
2025
Q2 | – | Sell |
-4,900
| Closed | -$11.4K | – | 14594 |
|
|
2025
Q1 | $11.4K | Sell |
4,900
-2,300
| -32% | -$6.3K | ﹤0.01% | 13489 |
|
|
2024
Q4 | $22K | Buy |
+7,200
| New | +$19.4K | ﹤0.01% | 13120 |
|
|
2024
Q3 | – | Sell |
-31,400
| Closed | -$101K | – | 15040 |
|
|
2024
Q2 | $101K | Buy |
31,400
+29,400
| +1,470% | +$105K | ﹤0.01% | 10908 |
|
|
2024
Q1 | $8.74K | Sell |
2,000
-2,900
| -59% | -$13.1K | ﹤0.01% | 13540 |
|
|
2023
Q4 | $24.9K | Sell |
4,900
-2,000
| -29% | -$9.58K | ﹤0.01% | 12434 |
|
|
2023
Q3 | $35.1K | Buy |
6,900
+6,500
| +1,625% | +$34.8K | ﹤0.01% | 12147 |
|
|
2023
Q2 | $2.14K | Sell |
400
-21,600
| -98% | -$128K | ﹤0.01% | 13823 |
|
|
2023
Q1 | $154K | Buy |
22,000
+16,500
| +300% | +$102K | ﹤0.01% | 10591 |
|
|
2022
Q4 | $25.9K | Buy |
+5,500
| New | +$24K | ﹤0.01% | 12904 |
|
Citadel Advisors's QIPT Position: Q1 2026 in Review
Citadel Advisors sold out of Quipt Home Medical (QIPT) in Q1 2026, closing a stake of 73,672 shares — an estimated $260K sold.
Citadel Advisors first reported a position in QIPT in Q4 2021 and held it in 16 quarters. The position peaked at $928K in Q2 2023. 0 funds tracked by Wall St. Rank hold QIPT as of Q1 2026.
- Citadel Advisors reported no remaining Quipt Home Medical position as of Q1 2026 after selling out during the quarter.
- Citadel Advisors sold 73,672 Quipt Home Medical shares in Q1 2026, an estimated $260K.
- Citadel Advisors first reported a position in Quipt Home Medical in Q4 2021 and held it in 16 quarters.
- Citadel Advisors's Quipt Home Medical position peaked at $928K in Q2 2023.
- 0 funds tracked by Wall St. Rank held Quipt Home Medical as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.